A detailed history of Nuveen Asset Management, LLC transactions in Revolution Medicines, Inc. stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 373,775 shares of RVMD stock, worth $13.8 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
373,775
Previous 384,668 2.83%
Holding current value
$13.8 Million
Previous $11 Million 9.19%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$26.56 - $33.55 $289,318 - $365,460
-10,893 Reduced 2.83%
373,775 $12 Million
Q4 2023

Feb 14, 2024

BUY
$18.35 - $34.12 $2.01 Million - $3.74 Million
109,723 Added 39.91%
384,668 $11 Million
Q3 2023

Nov 14, 2023

SELL
$25.17 - $35.05 $61,540 - $85,697
-2,445 Reduced 0.88%
274,945 $7.61 Million
Q2 2023

Aug 14, 2023

BUY
$20.28 - $27.0 $782,179 - $1.04 Million
38,569 Added 16.15%
277,390 $7.42 Million
Q1 2023

May 15, 2023

BUY
$20.76 - $30.09 $782,008 - $1.13 Million
37,669 Added 18.73%
238,821 $5.17 Million
Q4 2022

Feb 14, 2023

SELL
$17.68 - $25.53 $547,231 - $790,204
-30,952 Reduced 13.34%
201,152 $4.79 Million
Q3 2022

Nov 14, 2022

BUY
$17.46 - $26.0 $359,885 - $535,912
20,612 Added 9.75%
232,104 $4.58 Million
Q2 2022

Aug 15, 2022

BUY
$14.54 - $27.17 $36,698 - $68,577
2,524 Added 1.21%
211,492 $4.12 Million
Q1 2022

May 16, 2022

SELL
$17.31 - $26.4 $123,749 - $188,733
-7,149 Reduced 3.31%
208,968 $4.34 Million
Q4 2021

Feb 14, 2022

SELL
$24.35 - $33.7 $3.07 Million - $4.25 Million
-126,158 Reduced 36.86%
216,117 $5.44 Million
Q3 2021

Nov 12, 2021

SELL
$23.95 - $33.41 $663,534 - $925,624
-27,705 Reduced 7.49%
342,275 $9.42 Million
Q2 2021

Aug 16, 2021

BUY
$29.0 - $47.44 $4.72 Million - $7.71 Million
162,602 Added 78.41%
369,980 $11.7 Million
Q1 2021

May 17, 2021

BUY
$37.21 - $54.43 $2.03 Million - $2.97 Million
54,518 Added 35.67%
207,378 $9.52 Million
Q4 2020

Feb 16, 2021

BUY
$30.19 - $45.49 $21,525 - $32,434
713 Added 0.47%
152,860 $6.05 Million
Q3 2020

Nov 16, 2020

BUY
$22.61 - $34.8 $524,778 - $807,707
23,210 Added 18.0%
152,147 $5.29 Million
Q2 2020

Aug 14, 2020

BUY
$19.65 - $39.34 $950,116 - $1.9 Million
48,352 Added 60.0%
128,937 $4.07 Million
Q1 2020

May 14, 2020

BUY
$20.0 - $34.08 $1.61 Million - $2.75 Million
80,585 New
80,585 $1.77 Million

Others Institutions Holding RVMD

About Revolution Medicines, Inc.


  • Ticker RVMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,697,600
  • Market Cap $3.24B
  • Description
  • Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...
More about RVMD
Track This Portfolio

Track Nuveen Asset Management, LLC Portfolio

Follow Nuveen Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.